These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7910824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures.
    Jensen PH, Lorand L, Ebbesen P, Gliemann J.
    Eur J Biochem; 1993 May 15; 214(1):141-6. PubMed ID: 8099547
    [Abstract] [Full Text] [Related]

  • 3. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA.
    J Biol Chem; 2000 Aug 11; 275(32):24915-20. PubMed ID: 10816585
    [Abstract] [Full Text] [Related]

  • 4. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
    Dickinson JL, Norris BJ, Jensen PH, Antalis TM.
    Cell Death Differ; 1998 Feb 11; 5(2):163-71. PubMed ID: 10200461
    [Abstract] [Full Text] [Related]

  • 5. Identification of transglutaminase-reactive residues in S100A11.
    Robinson NA, Eckert RL.
    J Biol Chem; 1998 Jan 30; 273(5):2721-8. PubMed ID: 9446578
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE, Dobson JV, Greenberg CS.
    Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839
    [Abstract] [Full Text] [Related]

  • 10. Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2).
    Ritchie H, Lawrie LC, Mosesson MW, Booth NA.
    Ann N Y Acad Sci; 2001 Aug 15; 936():215-8. PubMed ID: 11460477
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells.
    Bendixen E, Borth W, Harpel PC.
    J Biol Chem; 1993 Oct 15; 268(29):21962-7. PubMed ID: 8104945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The glutamine residues reactive in transglutaminase-catalyzed cross-linking of involucrin.
    Simon M, Green H.
    J Biol Chem; 1988 Dec 05; 263(34):18093-8. PubMed ID: 2461365
    [Abstract] [Full Text] [Related]

  • 20. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase.
    Mehul B, Bawumia S, Hughes RC.
    FEBS Lett; 1995 Feb 27; 360(2):160-4. PubMed ID: 7875321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.